Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 6/20 | 0.59 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.57 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.57 |
| ▸ | APLNR | P35414 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Substance P SCHEMBL18769078 | 0.93 | OPRD1 (0.67) | OPRD1F2NMUR2NMUR1 | |
| Substance P SCHEMBL19057679 | 0.93 | OPRD1 (0.67) | OPRD1F2NMUR2NMUR1 | |
| Substance P SCHEMBL1116347 | 0.93 | OPRD1 (0.67) | OPRD1F2NMUR2NMUR1 | |
| Substance P SCHEMBL29831869 | 0.93 | OPRD1 (0.67) | OPRD1F2NMUR2NMUR1 | |
| SCHEMBL30013957 | 0.93 | OPRD1 (0.63) | OPRD1F2NMUR2NMUR1APLNR | |
| Substance P SCHEMBL17887651 | 0.93 | OPRD1 (0.67) | OPRD1F2NMUR2NMUR1 | |
| SCHEMBL30342262 | 0.91 | OPRD1 (0.71) | OPRD1NMUR2NMUR1 | |
| SCHEMBL31332027 | 0.91 | OPRD1 (0.71) | OPRD1NMUR2NMUR1 | |
| SCHEMBL31135242 | 0.89 | F2 (0.58) | OPRD1F2NMUR2NMUR1APLNR | |
| SCHEMBL8459610 | 0.87 | OPRM1 (0.61) | OPRD1NMUR2NMUR1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12122730-B2 | Methods of carbon-carbon bond fragmentation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-22 | — | — | US | disclosed |
| US-20220169580-A1 | METHODS OF CARBON-CARBON BOND FRAGMENTATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-02 | — | — | US | disclosed |
| EP-3944739-A2 | METHODS OF CARBON-CARBON BOND FRAGMENTATION | The Regents of the University of California (US) | 2022-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169580-A1 | METHODS OF CARBON-CARBON BOND FRAGMENTATION | CYCS, COX6C, COXFA4L2 | OPRD1 3561/4885F2 184/4885NMUR2 3797/4885 |
| US-12122730-B2 | Methods of carbon-carbon bond fragmentation | CYCS, COX6C, COXFA4L2 | OPRD1 3561/4885F2 184/4885NMUR2 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.